moxifloxacin has been researched along with violaceol II in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (violaceol II) | Trials (violaceol II) | Recent Studies (post-2010) (violaceol II) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 7 | 0 | 2 |
| Protein | Taxonomy | moxifloxacin (IC50) | violaceol II (IC50) |
|---|---|---|---|
| MPI protein | Homo sapiens (human) | 39.479 | |
| Vif | Human immunodeficiency virus 1 | 13.77 | |
| Tat | Human immunodeficiency virus 1 | 100 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 13.77 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daletos, G; Ebrahim, W; El-Neketi, M; Kalscheuer, R; Lewald, LI; Lin, W; Orfali, RS; Proksch, P; Rehberg, N | 1 |
1 other study(ies) available for moxifloxacin and violaceol II
| Article | Year |
|---|---|
Metabolites from the Fungal Endophyte Aspergillus austroafricanus in Axenic Culture and in Fungal-Bacterial Mixed Cultures.
Topics: Animals; Anti-Bacterial Agents; Aspergillus; Bacillus subtilis; Mice; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Sesquiterpenes; Staphylococcus aureus; Xanthones | 2016 |